Horne C, Spahn H, Mutschler E
Pharmakologisches Institut für Naturwissenschaftler, Johann Wolfgang Goethe-Universität, Frankfurt/Main, Fed. Rep. of Germany.
Arzneimittelforschung. 1987 Oct;37(10):1179-81.
The quantitative determination of the new antidepressant drug levoprotiline, the R-(-)-enantiomer of oxa-protiline (a-[methylamino)methyl)-9,10-ethanoanthracene-9(10H)-ethanol), in human biological material is described. Analysis is performed by alkaline extraction with n-heptane-isopropanol, subsequent fluorescence derivatisation with NBD chloride (4-chloro-7-nitrobenzofurazan), thin layer or high performance liquid chromatography, and fluorimetric measurement of the derivatisation product (lambda max ex. = 470 nm, lambda max em. = 525 nm). The sensitivity of the procedure (detection limit less than 1 ng/ml) permits the performance of pharmacokinetic studies after therapeutic doses.
本文描述了新型抗抑郁药物左普替林(奥沙普替林的R-(-)-对映体,即α-[(甲氨基)甲基]-9,10-亚乙基蒽-9(10H)-乙醇)在人体生物材料中的定量测定方法。分析过程包括用正庚烷-异丙醇进行碱性萃取,随后用NBD氯化物(4-氯-7-硝基苯并呋咱)进行荧光衍生化,再通过薄层色谱法或高效液相色谱法进行分析,并对衍生化产物进行荧光测定(激发波长最大值 = 470 nm,发射波长最大值 = 525 nm)。该方法的灵敏度(检测限小于1 ng/ml)使得在治疗剂量后能够进行药代动力学研究。